Zev Wajsman

3.3k total citations
83 papers, 2.5k citations indexed

About

Zev Wajsman is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Zev Wajsman has authored 83 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 32 papers in Pulmonary and Respiratory Medicine and 16 papers in Urology. Recurrent topics in Zev Wajsman's work include Bladder and Urothelial Cancer Treatments (34 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Urinary and Genital Oncology Studies (21 papers). Zev Wajsman is often cited by papers focused on Bladder and Urothelial Cancer Treatments (34 papers), Prostate Cancer Diagnosis and Treatment (21 papers) and Urinary and Genital Oncology Studies (21 papers). Zev Wajsman collaborates with scholars based in United States, France and Israel. Zev Wajsman's co-authors include Mark S. Soloway, David P. Wood, Antonio Puras-Báez, David G. McLeod, J. Edson Pontes, Ira Klimberg, Robert P. Huben, Roohollah Sharifi, Mark Garzotto and Robert Bahnson and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Zev Wajsman

79 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zev Wajsman United States 25 1.3k 1.2k 460 400 324 83 2.5k
J.M. Wolff Germany 18 1.3k 1.0× 576 0.5× 222 0.5× 241 0.6× 319 1.0× 93 2.0k
Rabi Tiguert United States 26 1.1k 0.9× 703 0.6× 300 0.7× 385 1.0× 268 0.8× 77 1.8k
A. Akdaş Türkiye 19 1.8k 1.4× 487 0.4× 188 0.4× 230 0.6× 507 1.6× 102 2.7k
Alan M. Nieder United States 23 823 0.6× 1.0k 0.9× 627 1.4× 235 0.6× 241 0.7× 70 1.9k
D. M. A. WALLACE United Kingdom 25 643 0.5× 1.2k 1.0× 446 1.0× 128 0.3× 281 0.9× 60 2.0k
Stephan Roth Germany 25 452 0.4× 1.2k 1.0× 635 1.4× 298 0.7× 400 1.2× 150 2.1k
Don Newling Netherlands 21 727 0.6× 470 0.4× 261 0.6× 261 0.7× 292 0.9× 56 1.4k
Mark A. Preston United States 30 1.1k 0.9× 1.6k 1.3× 386 0.8× 305 0.8× 615 1.9× 123 2.7k
Costantino Leonardo Italy 25 1.1k 0.8× 1.1k 0.9× 735 1.6× 385 1.0× 148 0.5× 153 2.2k
Joseph R. Drago United States 23 994 0.8× 737 0.6× 354 0.8× 331 0.8× 227 0.7× 104 2.0k

Countries citing papers authored by Zev Wajsman

Since Specialization
Citations

This map shows the geographic impact of Zev Wajsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zev Wajsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zev Wajsman more than expected).

Fields of papers citing papers by Zev Wajsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zev Wajsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zev Wajsman. The network helps show where Zev Wajsman may publish in the future.

Co-authorship network of co-authors of Zev Wajsman

This figure shows the co-authorship network connecting the top 25 collaborators of Zev Wajsman. A scholar is included among the top collaborators of Zev Wajsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zev Wajsman. Zev Wajsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iczkowski, Kenneth A., et al.. (2005). Small Lymphocytic Lymphoma Involving an Enlarging Complex Renal Cyst. Archives of Pathology & Laboratory Medicine. 129(1). 111–112. 4 indexed citations
2.
Hagan, Michael P., et al.. (2004). Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 59(2). 329–340. 48 indexed citations
3.
Neulander, Endre Z., et al.. (2003). The Role of the Simple Cystectomy in Urologic Surgery. PubMed. 539(Pt A). 535–547. 1 indexed citations
4.
Hagan, Michael P., Kathryn Winter, Donald S. Kaufman, et al.. (2003). RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 57(3). 665–672. 152 indexed citations
5.
Soloway, Mark S., et al.. (2002). NEOADJUVANT ANDROGEN ABLATION BEFORE RADICAL PROSTATECTOMY IN cT2bNxMo PROSTATE CANCER: 5-YEAR RESULTS. The Journal of Urology. 167(1). 112–116. 261 indexed citations
6.
Wilkinson, Simon, Leonard G. Gomella, Joseph A. Smith, et al.. (2002). Attitudes and Use of Complementary Medicine in Men with Prostate Cancer. The Journal of Urology. 2505–2509. 4 indexed citations
7.
Murphy, William M., et al.. (2001). SECOND OPINION OF ANATOMICAL PATHOLOGY: A COMPLEX ISSUE NOT EASILY REDUCED TO MATTERS OF RIGHT AND WRONG. The Journal of Urology. 165(6 Part 1). 1957–1959. 23 indexed citations
8.
Neulander, Endre Z., et al.. (2000). SIMPLE CYSTECTOMY IN PATIENTS REQUIRING URINARY DIVERSION. The Journal of Urology. 1169–1172. 1 indexed citations
9.
Neulander, Endre Z., et al.. (2000). SIMPLE CYSTECTOMY IN PATIENTS REQUIRING URINARY DIVERSION. The Journal of Urology. 164(4). 1169–1172. 26 indexed citations
10.
Caridi, James G., et al.. (1998). MASSIVE BLEEDING FROM ILEAL CONDUIT PERISTOMAL VARICES: SUCCESSFUL TREATMENT WITH THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT. The Journal of Urology. 159(1). 200–201. 17 indexed citations
11.
Garzotto, Mark & Zev Wajsman. (1998). ANDROGEN DEPRIVATION WITH SALVAGE SURGERY FOR RADIORECURRENT PROSTATE CANCER: RESULTS AT 5-YEAR FOLLOWUP. The Journal of Urology. 159(3). 950–955. 65 indexed citations
12.
Wajsman, Zev, et al.. (1997). THE BLADDER TUMOR ANTIGEN (BTA) TEST COMPARED TO VOIDED URINE CYTOLOGY IN THE DETECTION OF BLADDER NEOPLASMS. The Journal of Urology. 158(6). 2102–2106. 52 indexed citations
13.
Katz, Giora, Raymond L. Hackett, & Zev Wajsman. (1996). Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer. Urology. 47(6). 928–929. 3 indexed citations
14.
Garzotto, Mark, et al.. (1996). Multimodal therapy for neoplasms arising from a vesical diverticulum. Journal of Surgical Oncology. 62(1). 46–48. 19 indexed citations
15.
Ramon, Jacob, et al.. (1994). Morbidity of radical retropubic prostatectomy following previous prostate resection. Journal of Surgical Oncology. 55(1). 14–19. 46 indexed citations
16.
Pisters, Louis L. & Zev Wajsman. (1992). Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology. 40(3). 211–215. 24 indexed citations
18.
Klimberg, Ira, et al.. (1991). Intravesical bacillus Calmette-Guerinfor patients with high-risk superficial bladder cancer. Urology. 37(2). 180–184. 5 indexed citations
19.
Wajsman, Zev & Ira Klimberg. (1989). Treatment alternatives for invasive bladder cancer. Seminars in Surgical Oncology. 5(4). 272–281. 2 indexed citations
20.
Wajsman, Zev, et al.. (1983). Filling of the Obturator Nodes in Pedal Lymphangiography: Fact or Fiction. The Journal of Urology. 129(3). 533–535. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026